Trevi Therapeutics Inc (TRVI)

01:12 AM

Trevi Therapeutics stock hits 52-week high at 10.16 USD - Investing.com India

01:12 AM

05:22 AM

Multi factor analysis applied to Trevi Therapeutics Inc.July 2025 Earnings & Verified Momentum Watchlists - newser.com

05:22 AM

Oct 13, 2025

Trevi Therapeutics (NASDAQ:TRVI) Shares Gap DownTime to Sell? - MarketBeat

Oct 13, 2025

Oct 13, 2025

Does Trevi Therapeutics Inc. show high probability of reboundPortfolio Update Summary & Reliable Intraday Trade Plans - newser.com

Oct 13, 2025

Oct 13, 2025

Should I hold or sell Trevi Therapeutics Inc. stock in 2025July 2025 Volume & Community Consensus Picks - newser.com

Oct 13, 2025

Oct 13, 2025

How moving averages guide Trevi Therapeutics Inc. tradingJuly 2025 Pullbacks & Low Drawdown Investment Strategies - newser.com

Oct 13, 2025

Oct 10, 2025

Is Trevi Therapeutics Inc a good long term investmentMarket Timing Techniques & Insights From Wall Street Professionals - earlytimes.in

Oct 10, 2025

Oct 10, 2025

Is Trevi Therapeutics Inc. stock bottoming out2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com

Oct 10, 2025

Oct 10, 2025

How to use Fibonacci retracement on Trevi Therapeutics Inc.2025 Volatility Report & Fast Entry High Yield Tips - newser.com

Oct 10, 2025

Oct 10, 2025

Published on: 2025-10-10 03:52:14 - newser.com

Oct 10, 2025

Oct 10, 2025

What MACD and RSI say about Trevi Therapeutics Inc.Trade Entry Report & Long-Term Investment Growth Plans - newser.com

Oct 10, 2025

Oct 09, 2025

Trevi Therapeutics (NASDAQ:TRVI) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

Candlestick signals on Trevi Therapeutics Inc. stock todayJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

Trevi Therapeutics announces oral presentation and abstracts at Chest 2025 Annual Meeting - MarketScreener

Oct 08, 2025

Oct 08, 2025

Trevi Therapeutics Announces Oral Presentation And Abstracts At Chest 2025 Annual Meeting - TradingView

Oct 08, 2025

Oct 08, 2025

Phase 2b CORAL results: Trevi Therapeutics to present nalbuphine ER Oct 21; RIVER 2a PROs poster - Stock Titan

Oct 08, 2025

Oct 08, 2025

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives $21.75 Consensus Target Price from Analysts - Defense World

Oct 08, 2025

Oct 07, 2025

Trevi Therapeutics, Inc. $TRVI Stock Position Boosted by Farther Finance Advisors LLC - Defense World

Oct 07, 2025

Oct 06, 2025

Trevi Therapeutics Inc. stock trend forecast2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com

Oct 06, 2025

Oct 05, 2025

Analyzing net buyer seller activity in Trevi Therapeutics Inc.July 2025 Price Swings & Capital Efficient Trade Techniques - newser.com

Oct 05, 2025

Oct 04, 2025

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 04, 2025

Oct 03, 2025

Trevi Therapeutics (NASDAQ:TRVI) Hits New 12-Month HighHere's What Happened - MarketBeat

Oct 03, 2025

Oct 03, 2025

Trevi Therapeutics stock hits 52-week high at 9.93 USD By Investing.com - Investing.com Canada

Oct 03, 2025

Oct 03, 2025

Trevi Therapeutics stock hits 52-week high at 9.93 USD - Investing.com

Oct 03, 2025

Sep 29, 2025

What analysts say about Trevi Therapeutics Inc stockBearish Engulfing Patterns & Tap Into the Fastest-Growing Companies - earlytimes.in

Sep 29, 2025

Sep 24, 2025

Will earnings trigger a reversal in Trevi Therapeutics Inc.Recession Risk & High Return Stock Watch Alerts - newser.com

Sep 24, 2025

Sep 23, 2025

Regression analysis insights on Trevi Therapeutics Inc. performancePortfolio Return Summary & Low Risk Growth Stock Ideas - newser.com

Sep 23, 2025

Sep 23, 2025

Rhumbline Advisers Buys 10,608 Shares of Trevi Therapeutics, Inc. $TRVI - Defense World

Sep 23, 2025

Sep 23, 2025

Analyzing recovery setups for Trevi Therapeutics Inc. investorsTrade Performance Summary & Precise Buy Zone Tips - newser.com

Sep 23, 2025

Sep 23, 2025

Trevi Therapeutics (TRVI): Assessing Valuation as RIVER Trial Data Prepares for Major Scientific Debut - Yahoo Finance

Sep 23, 2025

Sep 22, 2025

Custom watchlist performance reports with Trevi Therapeutics Inc.Swing Trade & Reliable Trade Execution Plans - newser.com

Sep 22, 2025

Sep 20, 2025

Trading Recap: Will Trevi Therapeutics Inc. outperform tech stocksShort Setup & Smart Investment Allocation Tips - خودرو بانک

Sep 20, 2025

Sep 20, 2025

How Investors May Respond To Trevi Therapeutics (TRVI) Highlighting RIVER Trial Data at ERS 2025 - Yahoo Finance

Sep 20, 2025

Sep 19, 2025

Is Trevi Therapeutics Inc. stock entering bullish territoryIPO Watch & Target Return Focused Picks - newser.com

Sep 19, 2025

Sep 19, 2025

Quarterly Risk: Will Trevi Therapeutics Inc. outperform its industry peersBull Run & AI Optimized Trade Strategies - خودرو بانک

Sep 19, 2025

Sep 19, 2025

Hedge Fund Moves: Can Trevi Therapeutics Inc continue delivering strong returnsWeekly Stock Summary & Fast Entry Momentum Alerts - خودرو بانک

Sep 19, 2025

Sep 19, 2025

Long term hold vs stop loss in Trevi Therapeutics Inc.Quarterly Market Review & Fast Gaining Stock Reports - newser.com

Sep 19, 2025

Sep 19, 2025

Market Recap: Can ProShares Trust ProShares UltraShort Russell2000 grow without dilution2025 Technical Patterns & Safe Capital Growth Stock Tips - khodrobank.com

Sep 19, 2025

Sep 19, 2025

Market Catalysts: Is Trevi Therapeutics Inc forming a breakout patternPortfolio Gains Report & Fast Moving Stock Trade Plans - khodrobank.com

Sep 19, 2025

Sep 19, 2025

Combining machine learning predictions for Trevi Therapeutics Inc.Weekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com

Sep 19, 2025

Sep 18, 2025

Trevi Therapeutics to present two phase 2a River trial posters at ERS Congress 2025 - MarketScreener

Sep 18, 2025

Sep 18, 2025

Trevi Therapeutics To Present Two Phase 2a River Trial Posters At ERS Congress 2025 - TradingView

Sep 18, 2025

Sep 18, 2025

Trevi Therapeutics Announces Two Posters from the Phase 2a RIVER Trial Data Will be Featured at the European Respiratory Society (ERS) Congress 2025 - PR Newswire

Sep 18, 2025

Sep 17, 2025

Will Trevi Therapeutics Inc outperform its industry peers2025 Trading Recap & Long-Term Capital Growth Strategies - khodrobank.com

Sep 17, 2025

Sep 17, 2025

Trevi Therapeutics (NASDAQ:TRVI) Shares Down 4.6%Here's What Happened - MarketBeat

Sep 17, 2025